These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 1963503)
21. [Safety of blood products and B19 parvovirus]. Lefrère JJ; Maniez-Montreuil M; Morel P; Defer C; Laperche S Transfus Clin Biol; 2006 Oct; 13(4):235-41. PubMed ID: 16822687 [TBL] [Abstract][Full Text] [Related]
22. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. Lackritz EM AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988 [TBL] [Abstract][Full Text] [Related]
28. Strategies for safe blood. Reducing HIV transmission. AIDS Action; 1996; (34):2-3. PubMed ID: 12291928 [TBL] [Abstract][Full Text] [Related]
29. Current concepts on transmission of bacteria and parasites by blood components. Wendel S Vox Sang; 1994; 67 Suppl 3():161-74. PubMed ID: 7975485 [No Abstract] [Full Text] [Related]
30. [Risks of transfusions with blood and blood products]. van Aken WG; Engelfriet CP Ned Tijdschr Geneeskd; 1984 Nov; 128(44):2095-9. PubMed ID: 6095122 [No Abstract] [Full Text] [Related]
31. Current concepts on the transmission of bacteria and parasites by blood components. Wendel Neto S Sao Paulo Med J; 1995; 113(6):1036-52. PubMed ID: 8731290 [TBL] [Abstract][Full Text] [Related]
32. The prevalence of transfusion transmitted diseases in renal transplant recipients. Choudhury N; Naik S; Sharma RK; Elhence P; Ramesh V; Gupta RK Indian J Pathol Microbiol; 1996 Jul; 39(3):191-5. PubMed ID: 8972147 [TBL] [Abstract][Full Text] [Related]
33. [Viral safety in hemotherapy. Current aspects of hepatitis C and parvovirus B19 detection for plasma component therapy]. Sibrowski W; Kühnl P Beitr Infusionsther; 1990; 26():22-6. PubMed ID: 1703836 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood. Aggarwal V; Prakash C; Yadav S; Chattopadhya D Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388 [TBL] [Abstract][Full Text] [Related]
35. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [TBL] [Abstract][Full Text] [Related]
36. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion]. Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054 [No Abstract] [Full Text] [Related]
37. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589 [TBL] [Abstract][Full Text] [Related]